Ware Kuschner, M.D.

Professor of Medicine (Pulmonary, Allergy and Critical Care Medicine)

Academic Appointments

Professor - University Medical Line, Medicine - Pulmonary, Allergy & Critical Care Medicine

Administrative Appointments

Section Chief, Pulmonary, Critical Care and Sleep Medicine, VA Palo Alto Health Care System (2010 - Present)
Associate Chief for PACCM Faculty Affairs, Division of Pulmonary, Allergy and Critical Care Medicine, Stanford University School of Medicine (2018 - Present)
Medical Director, TeleQuit Smoking Cessation Program, Veterans Integrated Service Network 21, Veterans Health Administration (2006 - Present)
Chair, Clinical Bioethics Committee and Ethics Consultation Service, VA Palo Alto Health Care System (2001 - Present)
Chair, Research & Development Committee, VA Palo Alto Health Care System (2023 - Present)
Director, Board of Directors, Palo Alto Veterans Institute for Research (2023 - Present)
Member, Administrative Panel on Human Subjects in Medical Research, Panel 3, Stanford University (2008 - Present)
Member, Scientific Review Subcommittee, VA Palo Alto Health Care System (2008 - Present)

Honors & Awards

William A. Nelson Award for Excellence in Health Care Ethics, Veterans Health Administration (2011)
Clean Air Award for Medical Research, Breathe California (2010)
Outstanding Service Award, American Lung Association of San Francisco and San Mateo Counties (2006)
Faculty Teaching Award, Division of Pulmonary and Critical Care Medicine, Stanford University (2002)
Faculty Teaching Award, Division of Pulmonary and Critical Care Medicine, Stanford University (2000)
Cecile Lehman Mayer Research Award Finalist, American College of Chest Physicians (1996)
Research Award, Foundation for Occupational Health and Research (1996)
Walter Travel Fund Award, American Lung Association (1995)
Research Award, Foundation for Fellows in Asthma Research (1995)

Boards, Advisory Committees, Professional Organizations

Member, VA Executive Committee of Cooperative Study #595 “Pulmonary Health and Deployment to Southwest Asia and Afghanistan (2016 - Present)

Professional Education

Fellowship, University of California San Francisco, Pulmonary and Critical Care Medicine (1996)
Residency, Columbia Presbyterian Medical Center, New York, NY, Internal Medicine (1992)
M.D., Columbia University, College of Physicians and Surgeons (1989)

Current Research and Scholarly Interests

My principal area of academic interest is in occupational and environmental lung disease. I have conducted experimental research studying the acute effects of toxic inhalational exposure and observational research analyzing exposure-effects relationships in selected populations. I have a secondary area of academic interest in medical ethics.

Clinical Trials

A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos) Not Recruiting
More
This is a Phase III randomized, double-blind, parallel group, multi-center, 52-week COPD exacerbation and lung function study with PT009 320/9.6 μg, PT009 160/9.6 μg and PT005 9.6 μg, all administered BID.

Stanford is currently not accepting patients for this trial. For more information, please contact SPECTRUM, .
Lead Sponsor
Stanford Investigators
- Ware Kuschner, M.D.
View full details
A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Not Recruiting
More
The study evaluates the efficacy of fluticasone furoate/umeclidinium bromide/vilanterol (FF/UMEC/VI) to reduce the annual rate of moderate and severe exacerbations compared with dual therapy of FF/VI or UMEC/VI in subjects with COPD. Published studies which assessed the use of an 'open' triple therapy (use of Inhaled Corticosteroid \[ICS\]/ Long-acting Muscarinic Receptor Antagonists \[LAMA\])/ Long Acting Beta-Agonist \[LABA\] delivered via multiple inhalers) in moderate-severe COPD patients, reported improvements in lung function, Health Related Quality of Life (HRQoL), hospitalization rates and rescue medication use, compared to dual therapy (ICS/LABA) or LAMA alone. These studies have also shown similar safety profile with dual or monotherapy doses for periods of up to one year. Given the clinical experience with FF, UMEC and VI, and that the associated risks with these compounds are anticipated from their known pharmacology, the potential benefit of a new therapy option in patients with moderate to severe COPD supports the further development of the closed triple combination (delivered via one inhaler). In the current study subjects meeting all inclusion/exclusion criteria will complete 2-week run-in period; 52 week treatment period and a 1-week safety follow-up period. Eligible subjects will be randomized to one of the following double-blind treatment groups FF/UMEC/VI 100 micrograms (mcg)/62.5 mcg/25 mcg once daily (QD), FF/VI 100 mcg/25 mcg QD, or UMEC/VI 62.5 mcg/25 mcg QD

Stanford is currently not accepting patients for this trial. For more information, please contact SPECTRUM, .
Lead Sponsor
Stanford Investigators
- Ware Kuschner, M.D.
View full details
A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD Not Recruiting
More
The purpose of this study is to compare Symbicort in a pressurized metered-dose inhaler (pMDI) with formoterol and placebo in the long-term maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Stanford is currently not accepting patients for this trial. For more information, please contact Ware Kuschner, 6504935000 x 63544.
Lead Sponsor
Stanford Investigators
- Ware Kuschner, M.D.
View full details

2024-25 Courses

Independent Studies
- Directed Reading in Medicine
  MED 299 (Aut, Win, Spr, Sum)
- Early Clinical Experience in Medicine
  MED 280 (Aut, Win, Spr, Sum)
- Graduate Research
  MED 399 (Aut, Win, Spr, Sum)
- Medical Scholars Research
  MED 370 (Aut, Win, Spr, Sum)
- Undergraduate Research
  MED 199 (Aut, Win, Spr, Sum)

All Publications

Profiles With Related Publications

close
Amit Banga

Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Clinical Focus
Lung Transplantation, Heart-Lung Transplantation, Pulmonary Disease

35 Total Publications
close
Gerald Berry

Richard Kempson, M.D., Professor of Surgical Pathology
Clinical Focus
Pathology and Laboratory Medicine, Anatomic and Clinical Pathology
Research Interests
Cardiopulmonary and pulmonary transplant medicine; diagnostic surgical pathology

343 Total Publications
close
Lorinda Chung

Professor of Medicine (Immunology and Rheumatology) and, by courtesy, of Dermatology
Clinical Focus
Immunology and Rheumatology, Rheumatology, Scleroderma, Systemic, Connective Tissue Diseases
Research Interests
My research interests focus on all aspects of systemic sclerosis. I am currently involved in clinical, translational, and epidemiologic research in these areas, and dedicate a substantial portion of my research time to investigator-initiated and multi-center clinical trials of novel therapeutics for the treatment of systemic sclerosis.

380 Total Publications
close
Mary Kane Goldstein

Professor of Health Policy, Emerita
Research Interests
Health services research in primary care and geriatrics: developing, implementing, and evaluating methods for clinical quality improvement. Current work includes applying health information technology to quality improvement through clinical decision support (CDS) integrated with electronic health records; encoding clinical knowledge into computable formats in automated knowledge bases; natural language processing of free text in electronic health records; analyzing multiple comorbidities

187 Total Publications
close
Steven Goodman

Professor of Epidemiology and Population Health, of Medicine (Primary Care and Population Health) and, by courtesy, of Health Policy
Research Interests
I am interested in issues relating to the representation and measurement of evidence in medical research, and determinants of the truth of medical findings, using a Bayesian framework. I also do work in evidence synthesis, comparative effectiveness research, and the ethics of clinical research.

235 Total Publications
close
Paul Heidenreich, MD

Professor of Medicine (Cardiovascular)
Clinical Focus
Echocardiography, Cardiovascular Disease
Research Interests
My research interests include

1) The cost-effectiveness of new cardiovascular technologies.
Example: tests to screen asymptomatic patients for left ventricular systolic dysfunction.

2) Interventions to improve the quality of care of patients with heart disease. Examples: include clinical reminders and home monitoring.

3) Outcomes research using existing clinical and administrative datasets.

4) Use of echocardiography to predict prognosis (e.g. diastolic dysfunction).

954 Total Publications
close
Lynn Hildemann

Senior Associate Dean for Education and Professor of Civil and Environmental Engineering

98 Total Publications
close
Joe Le Hsu

Assistant Professor of Medicine (Pulmonary and Critical Care)
Clinical Focus
Pulmonary Disease, Pulmonary & Critical Care
Research Interests
I am interested in understanding the host-pathogen interaction between Aspergillus fumigatus and the lung transplant recipient.

52 Total Publications
close
Royal Kopperud

Lecturer

5 Total Publications
close
Helena Chmura Kraemer

Professor of Biostatistics in Psychiatry, Emerita
Research Interests
I am interested in the methodology pertinent to dealing with research problems where biological and behavioral interests meet. These interests have been applied not only in psychiatric research, but in those areas of Cardiology, Pediatrics and other fields of medicine in which behavioral research is becoming ever more salient.

482 Total Publications
close
Philip W. Lavori

Professor of Biomedical Data Science, Emeritus
Research Interests
Biostatistics, clinical trials, longitudinal studies, casual inference from observational studies, genetic tissue banking, informed consent. Trial designs for dynamic (adaptive) treatment regimes, psychiatric research, cancer.

347 Total Publications
close
Ann Leung

Professor of Radiology (Thoracic Imaging)
Clinical Focus
Diagnostic Radiology
Research Interests
High-resolution computed tomography of the thorax, particularly its application in the setting of acute lung disease in the immunocompromised host; quantitative assessment of abnormalities using thin-section CT; and enhancement characteristics of lung cancers on CT and MRI

156 Total Publications